Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 488 (CSE: $CURA.C) (OTCQX: $CURLF) (OTC: $MJNA) (CSE: $DIXI_U.C), (OTCQX: $DXBRF)
Today's podcast sponsored by Cannabis Suisse Corp.
(OTC: $CSUI), a fully licensed cannabis cultivation and distribution company in
Switzerland
Delta, Kelowna, BC, October 29, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/102920-StocksToWatch.mp3
Read
this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/10291CURA-CURLF-MJNA-DIXI-DXBRF.asp
Hear the investor ideas potcast on Spotify
Hear Investor ideas cannabis potcast on iTunes
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s podcast is
sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis
cultivation and distribution company in Switzerland, for recreational tobacco
products and medical CBD oils. The Company's facilities for producing cannabis
are based in Dietikon, Switzerland, and contain the art surveillance equipment
to enable an around the clock webcast. Cannabis Suisse grows high quality,
organic cannabis with sustainable, all-natural principles. The Company's
products are laboratory tested to ensure the end users have access to a
standardized, safe and consistent product. Cannabis Suisse proprietary
trademarked MoldStandard is a quantitative microbiology method for analyzing
yeast and mold counts in harvested cannabis plants. Cannabis Suisse proprietary
trademarked CannaMec is a method for quantifying and removing residual solvents
during packaging and storage of CBD products. Cannabis Suisse Corp. currently
sells via a distribution network of Swiss retailers and online shops, under the
retail brand Alpine Cannabis.
In
today’s podcast we look at a few public and private company announcements.
Dixie Brands Inc. (CSE: DIXI.U), (OTCQX: DXBRF) and BR Brands, LLC announced that the previously disclosed
reverse takeover transaction of Dixie by BR Brands will be completed on
Saturday, October 31, 2020. The combined company has been renamed BellRock
Brands Inc. and Dixie's stock symbol on the Canadian Securities Exchange will
be changed to "BRCK." Dixie anticipates that trading of its shares
will recommence on or about November 4, 2020.
"We
are pleased to announce the upcoming closing of the business combination of BR
Brands and Dixie. This transformative transaction was the result of a long-term
strategic and value focused approach to building a dominant house of brands
within the cannabis sector," said Andrew Schweibold, former Chairman of BR
Brands and new Chairman of BellRock.
"BellRock
unites two of the most established brands in cannabis to create an IP and
brand-focused multi-state operator, unique in its strategy and scale. Under
BellRock management, the platform is poised for exponential growth, through both
M&A and organic R&D, and is purposely built to cater to all of the
industry's fastest growing segments."
BellRock's
portfolio consists of two iconic cannabis brands with deep history, Mary's
Brands ("Mary's") and Dixie, as well as two growing, California-based
brands, Rebel Coast and Défoncé.
Mary's,
founded in 2013, is the innovator of cannabis and hemp-infused products for
adult use, medical, skincare, wellness and pet markets, and the company's
robust library of intellectual property includes a U.S. patent for its
acclaimed transdermal technology. Since 2010, Dixie has created a wide array of
award-winning beverages, gummies, mints, and taffies as well as two well
recognized CBD supplement brands; Aceso Wellness and Therabis. Together, the
BellRock brands offer one of the largest spectrums of high-quality consumer
packaged goods in the cannabis industry. With 11 brands and over 200 SKUs,
BellRock reaches nearly every key consumer group and addresses the needs of a
diverse cannabis consumer base. The BellRock manufacturing and distribution
footprint continues to expand and currently spans nine states, and the company
owns or manages production facilities in its largest markets.
"The
joining of BR Brands and Dixie is unique in that together, BellRock possesses
one of the industry's broadest branded product portfolios catering to the
growing and ever-evolving cannabis consumer. Our portfolio is one of the most
diversified in the industry and is based on our relentless pursuit of enhancing
the consumer experience," said Chuck Smith, Chief Executive Officer of
BellRock Brands.
BellRock
brings together a seasoned leadership team of CPG and cannabis executives with
unrivaled financial, capital markets and consumer brands expertise. The Board
of Directors of BellRock will be comprised of three nominees of BR Brands and
two nominees of Dixie. Andrew Schweibold, previously Chairman of BR Brands,
will serve as Chairman of the Board. Chuck Smith, former President and Chief
Executive Officer of Dixie, assumes the role of BellRock CEO and joins the
BellRock Board. Sat Joshi, former Chief Executive Officer of BR Brands, steps
down from the executive position and joins the Board. The Board of Directors
also includes Jonathan Rosenthal, Co-Founder and Managing Partner at Rose
Capital, and Brian Graham, a seasoned CPG industry executive.
BellRock
began executing its integration strategy earlier in the year, already yielding
operational synergies and unlocking opportunities to grow revenue and cash
flow. The company has already unified
its sales team in Colorado and efforts to consolidate manufacturing and sales
in other key markets are already underway.
"Our
mission is to build the first national cannabis house of brands," says
Smith, "We aim to accomplish this goal by earning our customers' loyalty
and trust, and want BellRock to be known for delivering the highest quality,
most consistent and broadest portfolio of cannabis infused products in the
industry."
BellRock
remains committed to growing shareholder value. The company's buy-and-build
growth strategy employs a three-pronged approach of enhancing its platform
through strategic acquisitions, prioritizing profitable organic revenue growth,
and continuously optimizing its costs and capital structure. On a pro forma
basis, assuming BR Brands and Dixie had combined as of January 1, 2020, BellRock
expects to generate in excess of $40 million in revenue in 2020, with clear
plans to deliver exponential revenue and cash flow growth in 2021 and beyond.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) announced today that it has expanded its
award-winning line of Select Oil brand products to its 15th state, Illinois -
the nation's second-largest adult-use market after California - starting with
its Select Elite Live cannabis oil cartridges.
Select,
America's #1 Cannabis Oil Brand, is a lifestyle brand that was acquired by
Curaleaf in February 2020. Select creates a variety of high-quality products
that can be found in over a thousand dispensaries across 15 states, including
Arizona, California, Colorado, Connecticut, Florida, Illinois, Maryland,
Michigan, Nevada, New York, Ohio, Oklahoma, Oregon, Massachusetts, and Maine.
As an industry leader, Select takes pride in having some of the most stringent
and progressive testing practices in the industry and is committed to
continuous innovation to ensure our customers get the best cannabis experience
possible.
Select
Elite Live combines high-quality, high-potency THC oil with live resin extract
derived from fresh, frozen flower. Created with a proprietary formula, Elite
Live is designed to capture the essence of the living plant with a higher
terpene content when compared to a traditional distillate cartridge. The
enhanced formula has quickly become a best-seller in every market where it has
launched; in Florida alone, sales surpassed $1
million in less than one month. The oil is delivered by Select's
unique cartridge technology, which helps to evenly distribute heat and deliver
enhanced purity, flavor, and quality.
"The
Select brand has worked diligently to earn its place as an industry leader and
is rapidly becoming the first nationally-recognized cannabis brand," said
Joe Bayern, President at Curaleaf. "Illinois is one of the largest
adult-use cannabis markets in the country and one that has worked incredibly
hard to address the need for reparation and normalization of our industry. We
look forward to becoming part of the Illinois community, and serving the
patients and consumers with the best in class cannabis consumer products
available anywhere."
In July
2020, Curaleaf closed on its acquisition of Grassroots, giving the company the
opportunity to continue developing innovative products and serving communities
across the United States, including Grassroots' native state of Illinois.
Select is slated to expand into Pennsylvania early next month. Both Illinois
and Pennsylvania are among the largest and fastest-growing cannabis markets in
the United States.
The
Illinois Department of Revenue (IDOR) recently
reported that, following the legalization of adult-use cannabis in
the state on January 1, marijuana sales have been record-breaking
month-over-month, contributing to the $100 million milestone of cannabis tax
revenue collected.
Select
products will be available at many of Illinois' leading dispensaries, including
Greenhouse's retail locations in Deerfield, Litchfield, Morris, Mokena and
Skokie which will fall under the Curaleaf umbrella and branding pending final
regulatory approval. To find a dispensary near you that carries Select
products, go to www.selectbetter.com and click "Find Us" for an
interactive map of locations.
Shoppers Drug Mart Inc. announced the opening of its MediSystem®
location in Edmonton. Owned and operated
by Shoppers Drug Mart, MediSystem Inc. is an established specialty pharmacy
that provides pharmaceutical dispensing and clinical pharmacy consulting services
to the senior housing community and group home facilities.
Located
at 12215-156 St NW in Edmonton, the new MediSystem Pharmacy is committed to
optimizing the health, wellness and safety of all facility residents through
the introduction of innovative technologies, continuing education, enhanced
clinical services and seamless medication delivery.
"Since
our inception in 1988 we've been bringing leading edge technology and personal
care to long term care residents across Canada," says Sandra Daniel, Vice
President of Operations and Clinical at MediSystem Pharmacy. "The opening
of our new location in Edmonton will allow us to continue to support the health
and well-being of the growing number of seniors in long term care and
retirement home facilities through the most advanced, dependable, and
personalized pharmacy care. Our investment today also reflects confidence in
the future direction of health care in Alberta."
The
Edmonton MediSystem staff will
include a dedicated pharmacy team, including operational and consultant
pharmacists to provide on-site, end-to-end support including one-on-one
counseling. Providing access to medication 24 hours a day, 7 days a week, 365
days a year, the team will be highly accessible, ensuring that all clinical
needs and emergency services are fully covered.
These pharmacists, specializing in senior care, will also provide
ongoing training and education that is tailored to optimize resident health
outcomes and improve quality of life. Through a series of programs and events,
including 1:1 training and hands on learning, MediSystem training focuses on continuous quality improvement
processes, disease and drug management, health and wellness as well as other
health-related topics.
MediSystem
Pharmacy has a legacy of being first to market with innovative, technical
solutions. Whether it be multi-dose strip packaging, comprehensive digital pen
system, ClientCare portal, e-Health solutions or state-of-the-art dispensing
machines, MediSystem Pharmacy's technology ensures management of all medication
information in a real time environment, resulting in exceptional accuracy.
Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary Kannaway®
has officially entered the U.S. cannabinol (CBN) market with the release of two
new CBN isolate products.
Not to
be confused with cannabidiol (CBD), which has gained significant popularity
over the past few years, CBN is another non-psychoactive cannabinoid found in
the cannabis plant. Like the Company’s full-spectrum CBD products, Kannaway®’s
CBN products are derived from all-natural hemp.
“We’re
very excited to become one of the first major hemp-derived product producers to
offer CBN,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “It is being
researched in several different studies, including a 300 person study just
announced on Oct. 28, for its potential sedation and sleep effects.”
This new
product line includes:
● Kannaway®
Pure CBN Liquid: Isolated CBN is combined with sustainably sourced medium-chain
triglyceride (MCT) oil, providing an abundant source of essential fatty acids
that help to enhance bioavailability naturally. Offered in a 1-ounce bottle
with a convenient dropper, each product delivers roughly 30 servings of 10 mg
of CBN each.
● Kannaway®
Pure CBN Gel Capsules: Isolated CBN and MCT oil are also combined, but are
presented in a convenient gel capsule form. They come in a 30-pack, with each
gel capsule containing 20 mg of pure CBN.
“Though
it may be too soon to predict the growth potential for the CBN market, analysts
at the Nutrition Business Journal predict that the sleep supplement market will
grow 30.1% this year,” said Kannaway CEO Blake Schroeder. “We intend to
continue to stay up-to-date with the most recent discoveries in cannabinoid
research and offer our customers the latest, most popular ingredients available
in sleep science and other categories.”
Once again, today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Investors can trade these stocks
and other ideas on our site using our list of
top stock trading apps including
Robinhood, Acorn, Stash and others.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. Disclosure: Cannabis Suisse Corp. (OTC: CSUI),is a paid featured company on
Investorideas.com
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to
regulations of each country. Please read Investorideas.com privacy
policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
